window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 16, 2026

  • News
  • About Us
Contact Us

Elmwood trial

  • Clinical Trials

    Late-breaking elafibranor data shows potential in primary sclerosing cholangitis (PSC)

    April 28, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • BNPP AM Alts invests $115M in ILiAD Biotechnologies to advance whooping cough vaccine
    Categories: Biotech, Global health, Immunology, Pharmaceuticals and therapeutics, Research & Development
  • Kainova Therapeutics raises $32m CAD Series B to advance immuno-oncology and inflammation pipeline
    Categories: Funding, Oncology, Pharmaceuticals and therapeutics
  • 5 Insights on Data Foundations From Top Pharma Leaders
    Categories: Artificial Intelligence, Data Management, Market Access & Commercialization, Pharmaceuticals and therapeutics, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top